PatentJul 2, 2026, 08:02 AM
Trust Stamp Files Provisional Patent for AI-Powered MDAS
AI Summary
Trust Stamp announced the filing of a U.S. Provisional Patent Application for its "Medical Diagnostic Assurance System" (MDAS). This LLM-based technology is designed to prevent critical issues like confirmation bias and hallucinations in medical diagnosis. MDAS will operate as a self-contained sovereign system with tokenized patient identities and uses a three-model consensus to challenge or reinforce practitioner diagnoses. The company is currently negotiating a pilot program and aims to launch the technology in Q1 2027.
Key Highlights
- Filed U.S. Provisional Patent Application No. 64/091,057.
- New patent titled "Medical Diagnostic Assurance System" (MDAS).
- MDAS is an LLM-based technology for medical diagnosis.
- Designed to avoid confirmation bias and hallucinations in diagnosis.
- Features tokenization of patient identities and a three-model consensus.
- Company is negotiating a pilot program for MDAS.
- Aims to launch MDAS technology live in Q1 2027.
- Trust Stamp previously held 27 issued/allowed patents and 7 pending.
Price Impact
More from IDAI